H.R. 1193House117th Congress (2021-2023)Enacted

Cardiovascular Advances in Research and Opportunities Legacy Act

Sponsored by Andy BarrRep. Andy Barr (R-KY)
Introduced February 22, 2021

AI-Generated Summary

Updated February 7, 2026 at 10:56 PM UTC

The Cardiovascular Advances in Research and Opportunities Legacy Act amends the Public Health Service Act to direct the NIH, working with the National Heart, Lung, and Blood Institute, to expand research, education, and awareness about valvular heart diseases. It establishes a program to fund studies using advanced imaging, investigate risk factors for sudden cardiac death, and improve public health data. The law also requires a workshop on mitral valve prolapse and authorizes $28 million each year from 2023‑2027 for related activities, affecting researchers, health agencies, and the public.

Key Provisions

  • The Secretary of HHS continues and expands research, education, and awareness activities on valvular heart diseases.
  • The NIH Director, in consultation with the NHLBI Director, may support or conduct research on valvular heart diseases, including advanced imaging and studies of sudden cardiac death risk factors.
  • Within two years, the NHLBI must convene a workshop of experts to identify research needs and recommendations for mitral valve prolapse.
  • HHS may award grants or contracts to public or nonprofit entities to increase education, improve data collection, and coordinate efforts on valvular heart disease prevention, prioritizing high‑impact populations.
  • The Secretary must coordinate activities across HHS agencies, share best practices with health providers, and ensure data quality on cardiac arrests.
  • Appropriations of $28 million are authorized for each fiscal year from 2023 through 2027 to fund these activities.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

32 earlier actions
Became Law Latest Action

Became Public Law No: 117-244.

December 20, 2022

View full timeline
HouseIntro Referral

Introduced in House

February 22, 2021

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

February 22, 2021

HouseCommittee

Referred to the Subcommittee on Health.

February 23, 2021

HouseCommittee

Subcommittee Consideration and Mark-up Session Held.

November 4, 2021

HouseCommittee

Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

November 4, 2021

HouseCommittee

Committee Consideration and Mark-up Session Held.

November 17, 2021

HouseCommittee

Ordered to be Reported (Amended) by Voice Vote.

November 17, 2021

HouseCommittee

Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-212.

December 8, 2021

HouseCalendars

Placed on the Union Calendar, Calendar No. 153.

December 8, 2021

HouseFloor

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

December 8, 2021 • 3:50 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H7518-7522)

December 8, 2021 • 3:50 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 1193.

December 8, 2021 • 3:50 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H7518)

December 8, 2021 • 4:31 PM

HouseFloor

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7518)

December 8, 2021 • 4:31 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

December 8, 2021 • 4:31 PM

HouseFloor

The title of the measure was amended. Agreed to without objection.

December 8, 2021 • 4:31 PM

SenateIntro Referral

Received in the Senate.

December 9, 2021

SenateIntro Referral

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

May 25, 2022

SenateCommittee

Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.

June 14, 2022

SenateCommittee

Committee on Health, Education, Labor, and Pensions. Reported by Senator Murray with an amendment in the nature of a substitute. Without written report.

July 12, 2022

SenateCalendars

Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.

July 12, 2022

SenateFloor

Measure laid before Senate by unanimous consent. (consideration: CR S6946-6947)

December 1, 2022

SenateFloor

The committee substitute withdrawn by Unanimous Consent.

December 1, 2022

SenateFloor

Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S6947)

December 1, 2022

SenateFloor

Message on Senate action sent to the House.

December 5, 2022

HouseResolving Differences

Mr. Pallone moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H8755-8756)

December 5, 2022 • 4:11 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on the Senate amendment to H.R. 1193.

December 5, 2022 • 4:12 PM

HouseNot Used

Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote.

December 5, 2022

HouseResolving Differences

On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote. (text: CR H8755)

December 5, 2022 • 4:23 PM

HouseResolving Differences

Motion to reconsider laid on the table Agreed to without objection.

December 5, 2022 • 4:23 PM

President

Presented to President.

December 16, 2022

Became Law

Signed by President.

December 20, 2022

Became Law

Became Public Law No: 117-244.

December 20, 2022

Floor Debate

18 members

What members said about H.R. 1193 on the floor

10 Republicans7 Democrats1 Independent
Andy Barr
Rep. Andy BarrR-KY-6 · Dec 8, 2021

Madam Speaker, I rise today in support of an issue that is obviously very personal to me, my legislation, the Cardiovascular Advances in Research and Opportunities Legacy Act, or the CAROL Act. I am…

Kevin McCarthy
Rep. Kevin McCarthyR-CA-23 · Dec 8, 2021

Mr. Speaker, I want to thank my friend for yielding, and I want to thank him for his friendship and his work. Mr. Speaker, I rise in support of this legislation. I want to thank Congressman Barr for…

Andy Barr
Rep. Andy BarrR-KY-6 · Dec 5, 2022

Mr. Speaker, I thank my colleagues for their support of this legislation. I rise today in support of an issue obviously that is very near and dear to my heart, our legislation, the Cardiovascular…

Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Jul 27, 2022

Madam Speaker, pursuant to House Resolution 1254, I call up the bill (H.R. 3771) to amend the Public Health Service Act to provide for research and improvement of cardiovascular health among the…

Pramila Jayapal
Rep. Pramila JayapalD-WA-7 · Jul 27, 2022

Madam Speaker, I thank Chairman Pallone for all the work he has done. I know he has a big API community in his district, so we appreciate his attention to these issues. I am very proud to rise in…

Show 8 more
Earl L. "Buddy" Carter
Rep. Earl L. "Buddy" CarterR-GA-1 · Jul 27, 2022

Madam Speaker, I yield myself such time as I may consume. Madam Speaker, I rise today to express my concerns with H.R. 3771, the South Asian Heart Health Awareness and Research Act of 2022. Investing…

Brett Guthrie
Rep. Brett GuthrieR-KY-2 · Dec 8, 2021

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 1193, the Cardiovascular Advances and Opportunities Legacy Act, or the CAROL Act,…

Sheila Jackson Lee
Rep. Sheila Jackson LeeD-TX-18 · Jul 27, 2022

Madam Speaker, I rise in support of H.R. 3771, known as the South Asian Heart Health Awareness and Research Act of 2021. This bill establishes programs that support heart-disease research and…

Anna G. Eshoo
Rep. Anna G. EshooD-CA-18 · Dec 8, 2021

Madam Speaker, I rise in strong support of seven bills that originated in the Health Subcommittee of Energy and Commerce which I have the privilege to chair. These bipartisan bills address the…

Mariannette Miller-Meeks
Rep. Mariannette Miller-MeeksR-IA-2 · Jul 27, 2022

Madam Speaker, I thank Representative Carter for yielding me time. Madam Speaker, I rise today in support of the Republican motion to recommit H.R. 3771. We can all agree that preventing myocardial…

Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Dec 8, 2021

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 1193) to amend title IV of the Public Health Service Act to direct the Director of the National Institutes of Health, in consultation…

Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Dec 5, 2022

Mr. Speaker, I move to suspend the rules and concur in the Senate amendment to the bill (H.R. 1193) to amend title IV of the Public Health Service Act to direct the Director of the National…

Steve Scalise
Rep. Steve ScaliseR-LA-1 · Dec 8, 2021

Madam Speaker, I rise with a heavy heart but in strong support of this legislation, the CAROL Act. Clearly, if you look at the policy, we are here today to expand research on valvular heart disease…

Show 9 more
John Joyce
Rep. John JoyceR-PA-13 · Dec 5, 2022

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in support of H.R. 1193, the Cardiovascular Advances and Opportunities Legacy Act, or the CAROL Act. I am excited…

Brad R. Wenstrup
Rep. Brad R. WenstrupR-OH-2 · Dec 8, 2021

Madam Speaker, I am proud to rise today in support of my good friend, my dear friend, Congressman Andy Barr and his legislation named, of course, in memory of his late wife, Carol. Andy knows Monica…

Judy Chu
Rep. Judy ChuD-CA-27 · Jul 27, 2022

Madam Speaker, I rise today in strong support of H.R. 3771, the bipartisan South Asian Heart Health Awareness and Research Act, which will not only raise awareness about the prevalence of heart…

Bill Huizenga
Rep. Bill HuizengaR-MI-2 · Dec 8, 2021

Madam Speaker, I appreciate the gentleman yielding, and I don't know how you follow Andy Barr and that story. Madam Speaker, Andy talked a lot about Carol, as he should, but we also want to talk…

Kathleen M. Rice
Rep. Kathleen M. RiceD-NY-4 · Dec 8, 2021

Mr. Speaker, I rise in strong support of the CAROL Act, which I am proud to co-lead with my friend, Representative Andy Barr, which will fund critical breakthroughs in our understanding of valvular…

Anna G. Eshoo
Rep. Anna G. EshooD-CA-18 · Jul 27, 2022

Madam Speaker, I rise in support of H.R. 3771, the ``South Asian Heart Health Awareness and Research Act of 2022.'' As Chairwoman of the House Health Subcommittee, I'm proud to have advanced this…

Cathy McMorris Rodgers
Rep. Cathy McMorris RodgersR-WA-5 · Dec 8, 2021

Madam Speaker, first, to my colleague and friend, Andy Barr, what a beautiful tribute to Carol. And I join my colleagues, everyone here today, in strong support of the CAROL Act. We love you. We love…

Jimmy Panetta
Rep. Jimmy PanettaD-CA-20 · Dec 8, 2021

Madam Speaker, I rise today to support the bipartisan CAROL Act and my good friend, Representative Andy Barr, and so many others in this Nation who either have valvular heart disease or have lost…

Angus S. King Jr.
Sen. Angus S. King Jr.I-ME · Dec 1, 2022

Madam President, I ask unanimous consent that the Senate proceed to the immediate consideration of Calendar No. 443, H.R. 1193. Madam President, I ask unanimous consent that the committee-reported…

Bill Text

9 versions available

Reading Mode
Latest
Enrolled BillPublication date not provided

One Hundred Seventeenth Congress of the United States of America

At the Second Session

Begun and held at the City of Washington on Monday, the third day of January, two thousand and twenty-two

H. R. 1193

AN ACT

To amend title IV of the Public Health Service Act to direct the Director of the National Institutes of Health, in consultation with the Director of the National Heart, Lung, and Blood Institute, to establish a program under which the Director of the National Institutes of Health shall support or conduct research on valvular heart disease, and for other purposes.

1.

Short title

This Act may be cited as the Cardiovascular Advances in Research and Opportunities Legacy Act.

2.

HHS valvular heart disease activities

(a)

In general

The Secretary of Health and Human Services (referred to in this section as the Secretary) shall, as appropriate, continue activities related to research, education, and awareness of valvular heart diseases.

(b)

NIH research related to valvular heart diseases

(1)

In general

The Director of the National Institutes of Health, in consultation with the Director of the National Heart, Lung, and Blood Institute, may support or conduct research regarding valvular heart diseases.

(2)

Support further research

In order to improve information on, and understanding of, causation and risk factors for valvular heart diseases, research conducted or supported under this subsection for such diseases may include the following:

(A)

Use of advanced technological imaging and other relevant methods to generate data related to valvular heart diseases.

(B)

Assessing potential risk factors for sudden cardiac arrest or sudden cardiac death from valvular heart diseases.

(C)

Other activities, as appropriate, in order to improve the availability of information on, and advance research related to, valvular heart diseases.

(3)

Mitral valve prolapse workshop

Not later than 2 years after the date of enactment of this Act, the Director of the National Heart, Lung, and Blood Institute shall, as appropriate, convene a workshop composed of subject matter experts and stakeholders to identify research needs and opportunities to develop recommendations for the identification and treatment of individuals with mitral valve prolapse, including such individuals who may be at risk for sudden cardiac arrest or sudden cardiac death.

(c)

Prevention activities to improve awareness of sudden cardiac death as a result of valvular heart diseases

(1)

In general

The Secretary may carry out activities to increase education and awareness of valvular heart diseases in order to reduce the incidence of sudden cardiac death caused by such diseases. The Secretary may—

(A)

award grants or contracts to public or nonprofit private entities to carry out activities under this subsection; and

(B)

directly, or through grants or contracts, provide technical assistance with respect to such activities.

(2)

Certain activities

Upon availability of applicable data, projects carried out under paragraph (1) may include—

(A)

continuing activities at the Centers for Disease Control and Prevention related to valvular heart diseases;

(B)

improving the awareness of the public concerning any risk factors for, the symptoms of, and the public health impact of, valvular heart diseases; and

(C)

enhancing public health data collection and improving the quality of such data, as appropriate, regarding cardiac arrests, including cardiac arrests that occur outside of the hospital.

(3)

Grant prioritization

The Secretary may, in awarding grants or entering into contracts pursuant to paragraph (1), give priority to entities seeking to carry out projects for populations most impacted by valvular heart diseases.

(4)

Coordination of activities

The Secretary shall, as appropriate, ensure that activities under this section are coordinated with other agencies and offices of the Department of Health and Human Services that carry out activities regarding valvular heart diseases.

(5)

Best practices

The Secretary shall, as applicable and appropriate, identify and disseminate best practices for relevant health care providers related to valvular heart diseases.

(d)

Authorization of appropriations

For purposes of carrying out this section, there are authorized to be appropriated $28,000,000 for each of fiscal years 2023 through 2027.

Speaker of the House of Representatives.

Vice President of the United States and President of the Senate.